Abstract
Immunoassay interferences are diverse in scope (1)(2)(3)(4)(5)(6)(7)(8) and are the subject of several recent large-scale studies (9)(10), opinions, and editorials (6)(11). Most interferences originate from components of the sample (e.g., human antianimal antibodies, lipid, bilirubin, drug metabolites) that interact with assay reagents or the detection system. The latest interference to rear its ugly head has been an interference originating from an additive in a blood collection tube (12)(13)(14). In this issue of Clinical Chemistry , Remaley et al. (13) have extended their original work (12) on this problem and have now identified a common tube surfactant as the probable …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
